SCHEMBL8395135

SCHEMBL8395135

CCCc1nc(O)ncc1C(=O)OCC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.72
KDM4E B2RXH2 4/20 0.45
NPC1 O15118 5/20 0.44
RAB9A P51151 4/20 0.44
LMNA P02545 2/20 0.44
HSD17B10 Q99714 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
ALDH1A1 P00352 5/20 0.44
MAPT P10636 3/20 0.44
MAPK1 P28482 2/20 0.44
ATM Q13315 1/20 0.44
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8394409 0.88 HSP90AA1 (0.55) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL1661270 0.84 HSP90AA1 (1.00) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL31357739 0.84 HSP90AA1 (0.70) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL8397025 0.84 HSP90AA1 (0.70) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL762042 0.81 HSP90AA1 (0.50) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL4592965 0.81 RAB9A (0.55) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL8398081 0.80 HSP90AA1 (0.69) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL8394462 0.80 HSP90AA1 (0.49) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL8394445 0.79 RAB9A (0.54) HSP90AA1KDM4ENPC1RAB9ALMNA
SCHEMBL8738554 0.78 KDM4E (0.61) HSP90AA1KDM4ENPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935966-A COMPOUNDS THAT BLOCK THE ACTIVATION OF TRANSCRIPTION FACTORS THROUGH INHIBITION OF A FAMILY OF SPECIFIC KINASES, DECREASING PROINFLAMMATORY PROTEINS TO TREAT AUTOIMMUNE DISEASES AND AS GENERAL ANTIINFLAMMATORY AGENTS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-10 US disclosed
US-5852028-A Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions SIGNAL PHARMACEUTICALS, INC. (US) 1998-12-22 US disclosed
WO-1998038171-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-03 WO disclosed
WO-1997009325-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1997-03-13 WO disclosed